Jason E. Barkeloo will attend invitation-only blockchain open science meetings, which will include meeting ultra high networth investors.
These meetings are inline with Open Therapeutics emerging product offering that uses blockchain in its management of grant funding.
This is embodied in the Company’s U.S. non-provisional patent filing US 2019 / 0080369 A1 (20190080369).
This patent filing enables grant funders to issue grants using the Company’s https://Therapoid.net platform and the technology manages the grant from start to finish, in conjunction with the scientific community. This technology will significantly reduce the time and cost of the grant funder’s funding process.
The Company was selected to attend at no cost by the Hong Kong Trade Development Council (HKTDC).
More about the 2020 Asian Financial Forum conference is at: http://www.hktdc.com/ncs/aff2020/en/main/index.html.
